Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. - Wikidata - wikimedia - TriplyDB

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

http://www.wikidata.org/entity/Q38327752

about

Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling Mechanisms linking excess adiposity and carcinogenesis promotion The Role of Human Aldo-Keto Reductases in the Metabolic Activation and Detoxication of Polycyclic Aromatic Hydrocarbons: Interconversion of PAH Catechols and PAH o-Quinones Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking.The aldo-keto reductases (AKRs): Overview.Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases.Aldo-Keto Reductases 1B in Endocrinology and Metabolism.Tanshinones: sources, pharmacokinetics and anti-cancer activities Network insights on oxaliplatin anti-cancer mechanisms.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Effect of microRNA-21 on the proliferation of human degenerated nucleus pulposus by targeting programmed cell death 4.Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.Mechanisms linking obesity and cancer TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma.A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells.Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.

P2860

Q21133890-3A043358-0951-4AB9-868E-9351AD75A01C Q27022929-4BBC1B3E-965D-4D14-A8CD-E4F0BA27BF25 Q28712007-0D7B0E1C-24BA-4030-92CE-CFE0EEBB1EA6 Q34028973-0A1FE80E-77DD-470B-9C34-ED121C1522B5 Q34079748-CEB23A6E-7EF8-4C0D-BF20-ED8B21994864 Q34432183-3B875D7D-400D-44DC-9071-92FEEE0914C9 Q35147435-C673F904-EBAD-46E4-9C96-18B81C22805D Q35305934-9630837D-857F-47DD-BCED-7E756DFE39A7 Q35825211-D25D80AC-ED1E-4107-92EB-052300F1EE8E Q36135903-6C6A3BEF-D2BC-451D-8A63-2BF76EA97BDF Q36396623-4569ECCF-A9EB-450C-86AD-EBE2401B8FB5 Q36578240-598F18E1-1975-469B-AE17-7E2C86FAE722 Q36656870-13F9D7F5-DE0A-450E-963C-77F4EC927E81 Q36981104-7D02BD67-9502-41E6-8047-4C2F917AF886 Q37067080-EAC0086D-4E1E-47A6-A0E5-FA0D4A67CAD8 Q37154242-6A7F1124-0D7C-4B27-A379-DCF20F67DBF5 Q37209580-C03F4D63-744B-4ED1-B590-EB0F384FD8DF Q37536701-3002B66E-35EF-4A34-AB09-35242433526A Q37623620-E3A8115B-7E37-4369-A057-20F082859F71 Q38814355-901544BC-EC30-4167-BEE1-2C03E41D3438 Q38834978-49E83223-228C-453A-9161-B515CF9B2147 Q39072349-7886BCFC-B2E3-4F09-A667-20F6662C2B89 Q39170232-D6A53F79-A0CB-4899-BA04-0F99E4716BC7 Q40835917-E8091398-95D7-41D6-B58B-6849335C2C2C Q44652572-C7FB25B4-7E6E-4B44-A785-1A40076EE473

P2860

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

http://www.wikidata.org/entity/Q38327752

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Epidermal growth factor induce ...... epatocellular carcinoma cells.

@en

type

label

Epidermal growth factor induce ...... epatocellular carcinoma cells.

@en

prefLabel

Epidermal growth factor induce ...... epatocellular carcinoma cells.

@en

P1433

Q38327752-68FF92FC-B758-406F-BF7A-F333F8B04859

P1476

Q38327752-6CC57CA8-395A-4475-A6C1-183E640CC58A

P2093

Q38327752-06C922A4-086E-4661-8E73-ECABC0E781E4

Q38327752-31D48431-BB2C-479F-AD1A-253D8A38D19B

Q38327752-4111F047-43D9-4CC7-8401-33B65F3E3330

Q38327752-420BCEB8-B2C0-4207-A0DC-9703C80FFD83

Q38327752-5206CF55-0F62-4CFC-811D-706D3EAB70B8

Q38327752-60C9DB6E-483E-40DA-951C-56EFC725C537

Q38327752-6801BDCB-913F-4638-9E56-1FF759C6AFC5

Q38327752-6CC1987E-1EF8-4076-A9F6-6DDA578D6E84

Q38327752-71572FAF-FE3F-43D6-BE4D-DC97DA95D9C8

Q38327752-C4DF24DD-DAE9-47E7-A69B-29CCCCBAB3BC

P2860

Q38327752-09773B57-B131-4EEA-A194-EF828DFB4839

Q38327752-0DD22E9D-CF8B-41D7-A78E-E33D9C003676

Q38327752-0F08A1DF-4303-458B-A5F1-078AEE1C5709

Q38327752-200127BE-38DA-4458-BE23-4D85A2071AC3

Q38327752-24C909B6-F3C7-4169-96B5-BB7EE96D1FE8

Q38327752-295556F7-9B35-41F0-BD34-7BA696C323A5

Q38327752-2CE0756E-0640-4920-9E8E-38DBDEC12DBC

Q38327752-2EF75549-6C90-4312-8535-92A2D6E9E113

Q38327752-2F1EDD62-7222-4AFD-904A-7E37FC194F4B

Q38327752-319E180D-C40F-4CE0-A1D6-DEB0B6CA7504

P304

Q38327752-35276391-B15B-4963-BD38-25EA71E0202F

P31

Q38327752-C1E29F59-E0C2-4FAC-9917-5DA1EFB39DF4

P356

Q38327752-4CF71629-3AFB-47CD-80F0-75DDD1A2F33D

P407

Q38327752-50B6499C-EED6-4AAD-8582-D931D8EB29D8

P433

Q38327752-8FD06064-C6B7-4F53-B488-7E56D25ACC6B

P478

Q38327752-406AD6D6-C926-452F-B50C-5238563B2FD8

P50

Q38327752-D3347902-22EA-4E74-A9FD-6FC4D57E96A3

P577

Q38327752-3DF2D90B-228E-43C3-8C1E-C01200665C10

P698

Q38327752-79DB01C9-EB75-43C7-9A5A-B0FE4DAE2146

P356

P1433

Biochemical Journal

P1476

Epidermal growth factor induce ...... epatocellular carcinoma cells.

@en

P2093

Ahmed Al-Salman

http://www.w3.org/2001/XMLSchema#string

Chenfei Huang

http://www.w3.org/2001/XMLSchema#string

Deliang Cao

http://www.w3.org/2001/XMLSchema#string

Di-Xian Luo

http://www.w3.org/2001/XMLSchema#string

Jun Ma

http://www.w3.org/2001/XMLSchema#string

Mei Chris Huang

http://www.w3.org/2001/XMLSchema#string

Ruilan Yan

http://www.w3.org/2001/XMLSchema#string

Yi Shen

http://www.w3.org/2001/XMLSchema#string

Yin-Yuan Mo

http://www.w3.org/2001/XMLSchema#string

Yiwen Bu

http://www.w3.org/2001/XMLSchema#string

P2860

Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells

Identification and characterization of a novel human aldose reductase-like gene

A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

Lipid rafts and signal transduction

EAPII interacts with ETS1 and modulates its transcriptional function

The EGF receptor family: spearheading a merger of signaling and therapeutics

Insulin and EGF Receptors Integrate the Ras and Rap Signaling Pathways

Pivotal role of c-Fos in nitric oxide synthase 2 expression in airway epithelial cells.

Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.

Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma.

P304

273-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ20111322

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

442

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22329800

http://www.w3.org/2001/XMLSchema#string